Sage Journals: Discover world-class research

Abstract

Keywords

angioplasty chronic limb-threatening ischemia (CLTI)claudication endovascular revascularization peripheral artery disease (PAD)

Get full access to this article

View all access options for this article.

References

Evans

Solomon

Ratchford

EV.

Vascular Disease Patient Information Page: Peripheral artery disease – 2025 update. Vasc Med 2025; 30: 384–388.

Gornik

Aronow

Goodney

, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2024; 149: e1313–e1410.

Conte

Bradbury

Kolh

, et al.; GVG Writing Group. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019; 69: 3S–125S.e40.

Farber

Menard

Conte

, et al.; BEST-CLI Investigators. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med 2022; 387: 2305–2316.

Bonaca

Bauersachs

Anand

, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med 2020; 382: 1994–2004.

Vascular Disease Patient Information Page: What to expect with endovascular revascularization for peripheral artery disease (PAD)

Abstract

Keywords

Get full access to this article

References